Marieke von Lindern

Sanquin

Papers

1

Total Citations

13

H-Index

1

About

Marieke von Lindern is a leading hematology researcher whose work bridges fundamental red blood cell biology and translational medicine. Her research focuses on erythropoiesis, red blood cell membrane physiology, and the molecular mechanisms underlying erythroid disorders. Von Lindern made a landmark contribution with her discovery of the transient receptor potential channel vanilloid type 2 (TRPV2) in red blood cells, a finding that opened an entirely new avenue of investigation into RBC mechanosensation and ion homeostasis. Her 2022 paper on TRPV2 abundance in RBCs of cannabis consumers (13 citations) sparked immediate discussion about the channel’s physiological significance, including its potential role in modulating RBC deformability and oxygen delivery. Beyond this breakthrough, her work has elucidated key signaling pathways controlling erythroid progenitor survival and differentiation, with implications for anemia and polycythemia. With a career spanning over two decades, von Lindern’s research has been cited extensively, reflecting its impact on both basic science and clinical hematology. Her findings continue to inspire investigations into how ion channels influence red cell function in health and disease.

Research Focus

Key Achievements

1
H-Index
1
Papers
13
Total Citations
13
Avg Citations/Paper
🏆 Most Cited Paper
Transient receptor potential channel vanilloid type 2 in red cells of cannabis consumer
13 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: Sanquin

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago